Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Theralase (TLT) grants 7,860,000 stock options at $ 0.25

<< Previous

Bullboard Posts

Next >>

Comment by Infinityon Nov 27, 2022 5:30pm

218 Views

Post# 35132353

RE:RE:Theralase (TLT) grants 7,860,000 stock options at $ 0.25

99942 Apophis, I agree with everything that you mentioned. However, the RISK in this that the current management can sell the company or the rights to patents at let us say at 10% premium to current market price of $ 0.30 per share. Vote in favour of the sale. The current managment could very well negotiate for a Multi Milllion Dollar Pay checks (Lucrative incentives and options) in the future company after the sale or merger. All the retail share holders who took the risk all along will be left with $0.33 per share. Just think about it. This would be perfectly legal!!

<< Previous

Bullboard Posts

Next >>

Soma Gold poised to extend profitable track record